Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry Pairaudeau

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Chemmedchem|April 27, 2011
The discovery of MMP7 inhibitors exploiting a novel selectivity triggerKarl Edman, Mark Furber, Paul Hemsley, et al.
Chemical Science|August 7, 2018
Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligaseEilidh K Leitch, Nagarajan Elumalai, Maria Fridén-Saxin, et al.
Journal of the American Chemical Society|March 19, 2024
Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer CellsAndrew T Ball, Soran Mohammed, Cyrielle Doigneaux, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
The discovery of new spirocyclic muscarinic M3 antagonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2009
Discovery of small molecule human C5a receptor antagonistsHitesh J Sanganee, Andrew Baxter, Simon Barber, et al.
The Journal of Biological Chemistry|November 7, 2013
Potent reversible inhibition of myeloperoxidase by aromatic hydroxamatesLouisa V Forbes, Tove Sjögren, Françoise Auchère, et al.
Journal of Medicinal Chemistry|July 11, 2003
QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonistsRupert P Austin, Patrick Barton, Roger V Bonnert, et al.
Nature Reviews. Drug Discovery|June 20, 2015
An analysis of the attrition of drug candidates from four major pharmaceutical companiesMichael J Waring, John Arrowsmith, Andrew R Leach, et al.
Chemical Science|August 5, 2021
Highly efficient on-DNA amide couplings promoted by micelle forming surfactants for the synthesis of DNA encoded librariesJames H Hunter, Matthew J Anderson, Isaline F S F Castan, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonistsStephen Connolly, Lilian Alcaraz, Andrew Bailey, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Chemmedchem|April 27, 2011
The discovery of MMP7 inhibitors exploiting a novel selectivity triggerKarl Edman, Mark Furber, Paul Hemsley, et al.
Chemical Science|August 7, 2018
Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligaseEilidh K Leitch, Nagarajan Elumalai, Maria Fridén-Saxin, et al.
Journal of the American Chemical Society|March 19, 2024
Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer CellsAndrew T Ball, Soran Mohammed, Cyrielle Doigneaux, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
The discovery of new spirocyclic muscarinic M3 antagonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2009
Discovery of small molecule human C5a receptor antagonistsHitesh J Sanganee, Andrew Baxter, Simon Barber, et al.
The Journal of Biological Chemistry|November 7, 2013
Potent reversible inhibition of myeloperoxidase by aromatic hydroxamatesLouisa V Forbes, Tove Sjögren, Françoise Auchère, et al.
Journal of Medicinal Chemistry|July 11, 2003
QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonistsRupert P Austin, Patrick Barton, Roger V Bonnert, et al.
Nature Reviews. Drug Discovery|June 20, 2015
An analysis of the attrition of drug candidates from four major pharmaceutical companiesMichael J Waring, John Arrowsmith, Andrew R Leach, et al.
Chemical Science|August 5, 2021
Highly efficient on-DNA amide couplings promoted by micelle forming surfactants for the synthesis of DNA encoded librariesJames H Hunter, Matthew J Anderson, Isaline F S F Castan, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonistsStephen Connolly, Lilian Alcaraz, Andrew Bailey, et al.
Pageof 3